1. |
Kim J, Gosnell JE, Roman SA. Geographic influences in the global rise of thyroid cancer. Nat Rev Endocrinol, 2020, 16(1): 17-29.
|
2. |
Feng JW, Wu WX, Qi GF, et al. Nomograms based on sonographic and clinicopathological characteristics to predict lateral lymph node metastasis in classic papillary thyroid carcinoma. J Endocrinol Invest, 2022, 45(11): 2043-2057.
|
3. |
Wang Y, Deng C, Shu X, et al. Risk factors and a prediction model of lateral lymph node metastasis in cN0 papillary thyroid carcinoma patients with 1-2 central lymph node metastases. Front Endocrinol (Lausanne), 2021, 12: 716728. doi: 10.3389/fendo.2021.716728.
|
4. |
Haugen BR, Alexander EK, Bible KC, et al. 2015 American thyroid association management guidelines for adult patients with thyroid nodules and differentiated thyroid cancer: The American Thyroid Association guidelines task force on thyroid nodules and differentiated thyroid cancer. Thyroid, 2016, 26(1): 1-133.
|
5. |
中华医学会内分泌学分会, 中华医学会外科学分会甲状腺及代谢外科学组, 中国抗癌协会头颈肿瘤专业委员会, 等. 甲状腺结节和分化型甲状腺癌诊治指南(第二版). 国际内分泌代谢杂志, 2023, 43(2): 149-194.
|
6. |
Haddad RI, Bischoff L, Ball D, et al. Thyroid carcinoma, version 2. 2022, NCCN clinical practice guidelines in oncology. J Natl Compr Canc Netw, 2022, 20(8): 925-951.
|
7. |
Luisa Garo M, Deandreis D, Campennì A, et al. Accuracy of papillary thyroid cancer prognostic nomograms: a systematic review. Endocr Connect, 2023, 12(4): e220457. doi: 10.1530/EC-22-0457.
|
8. |
Zhan S, Luo D, Ge W, et al. Clinicopathological predictors of occult lateral neck lymph node metastasis in papillary thyroid cancer: A meta-analysis. Head Neck, 2019, 41(7): 2441-2449.
|
9. |
Lai SW, Fan YL, Zhu YH, et al. Machine learning-based dynamic prediction of lateral lymph node metastasis in patients with papillary thyroid cancer. Front Endocrinol (Lausanne), 2022, 13: 1019037. doi: 10.3389/fendo.2022.1019037.
|
10. |
Perrier ND, Brierley JD, Tuttle RM. Differentiated and anaplastic thyroid carcinoma: Major changes in the American Joint Committee on Cancer eighth edition cancer staging manual. CA Cancer J Clin, 2018, 68(1): 55-63.
|
11. |
Sun Y, Sun W, Xiang J, et al. Nomogram for predicting central lymph node metastasis in T1–T2 papillary thyroid cancer with no lateral lymph node metastasis. Front Endocrinol (Lausanne), 2023, 14: 1112506. 10.3389/fendo. 2023.1112506.
|
12. |
王志宏, 张浩. T1–T2期单侧甲状腺乳头状癌伴同侧颈侧区淋巴结转移时甲状腺原发灶切除范围研究进展. 中国实用外科杂志, 2022, 42(3): 289-292.
|
13. |
Moons KG, Altman DG, Reitsma JB, et al. Transparent Reporting of a multivariable prediction model for Individual Prognosis or Diagnosis (TRIPOD): explanation and elaboration. Ann Intern Med, 2015, 162(1): W1-W73. doi: 10.7326/M14-0698.
|
14. |
Caliskan O, Unlu MT, Yanar C, et al. Predictive factors affecting the development of lateral lymph node metastasis in papillary thyroid cancer. Sisli Etfal Hastan Tip Bul, 2023, 57(3): 312-319.
|
15. |
Zhang T, He L, Wang Z, et al. Risk factors of cervical lymph node metastasis in multifocal papillary thyroid cancer. Front Oncol, 2022, 12: 1003336. doi: 10.3389/fonc.2022.1003336.
|
16. |
Zhou T, Huang W, Wang X, et al. Global burden of head and neck cancers from 1990 to 2019. iScience, 2024, 27(3): 109282. doi: 10.1016/j.isci.2024.109282.
|
17. |
Zhuo X, Yu J, Chen Z, et al. Dynamic Nomogram for Predicting Lateral Cervical Lymph Node Metastasis in Papillary Thyroid Carcinoma. Otolaryngol Head Neck Surg, 2022, 166(3): 444-453.
|
18. |
Zhang J, Zhou X, Yao F, et al. TIPARP as a prognostic biomarker and potential immunotherapeutic target in male papillary thyroid carcinoma. Cancer Cell Int, 2024, 24(1): 34.
|
19. |
Kim M, Kim SJ, Ha SY, et al. BRAFV600E Mutation Enhances Estrogen-Induced Metastatic Potential of Thyroid Cancer by Regulating the Expression of Estrogen Receptors. Endocrinol Metab (Seoul), 2022, 37(6): 879-890.
|
20. |
Heng Y, Yang Z, Cao P, et al. Lateral Involvement in Different Sized Papillary Thyroid Carcinomas Patients with Central Lymph Node Metastasis: A Multi-Center Analysis. J Clin Med, 2022, 11(17): 4975.
|
21. |
Zhong H, Zeng Q, Long X, et al. Risk factors analysis of lateral cervical lymph node metastasis in papillary thyroid carcinoma: a retrospective study of 830 patients. World J Surg Oncol, 2024, 22(1): 162.
|
22. |
Deng Y, Zhang J, Wang J, et al. Risk factors and prediction models of lymph node metastasis in papillary thyroid carcinoma based on clinical and imaging characteristics. Postgrad Med, 2023, 135(2): 121-127.
|
23. |
Shao L, Wang Z, Dong W, et al. Risk factors associated with preferential lateral lymph node metastasis in papillary thyroid carcinoma. Cancer Med, 2023, 12(22): 20670-20676.
|
24. |
Zhao L, Wu F, Zhou T, et al. Risk factors of skip lateral cervical lymph node metastasis in papillary thyroid carcinoma: a systematic review and meta-analysis. Endocrine, 2022, 75(2): 351-359.
|
25. |
Heng Y, Feng S, Yang Z, et al. Features of Lymph Node Metastasis and Structural Recurrence in Papillary Thyroid Carcinoma Located in the Upper Portion of the Thyroid: A Retrospective Cohort Study. Front Endocrinol (Lausanne), 2022 Jan 25: 12: 793997.
|
26. |
Song M, Huang Z, Wang S, et al. Predictive factors of lateral lymph node metastasis in conventional papillary thyroid carcinoma. Gland Surg, 2020, 9(4): 1000-1007.
|
27. |
Aygun N, Kostek M, Isgor A, et al. Role and Extent of Neck Dissection for Neck Lymph Node Metastases in Differentiated Thyroid Cancers. Sisli Etfal Hastan Tip Bul, 2021, 55(4): 438-449.
|
28. |
Weng HY, Yan T, Qiu WW, et al. The Prognosis of Skip Metastasis in Papillary Thyroid Microcarcinoma Is Better Than That of Continuous Metastasis. J Clin Endocrinol Metab, 2022, 107(6): 1589-1598.
|
29. |
Liu W, Zhang D, Jiang H, et al. Prediction model of cervical lymph node metastasis based on clinicopathological characteristics of papillary thyroid carcinoma: a dual-center retrospective study. Front Endocrinol (Lausanne), 2023 Sep 11: 14: 1233929.
|
30. |
Gong J, Zhu B, Liu W, et al. Risk Factors for Lymph Node Metastasis in Papillary Thyroid Carcinoma: A Retrospective Study. Horm Metab Res, 2023, 55(5): 315-322.
|
31. |
Xu B, Gu SY, Zhou NM, et al. Association between thyroid stimulating hormone levels and papillary thyroid cancer risk: A meta-analysis. Open Life Sci, 2023, 18(1): 20220671.
|
32. |
Mao A, An N, Wang J, et al. Association between preoperative serum TSH and tumor status in patients with papillary thyroid microcarcinoma. Endocrine, 2021, 73(3): 617-624.
|